• Qui Tam
  • SEC
  • CFTC
  • FCPA
  • Whistleblower Resources
  • FAQS
Subscribe
Donate
No Result
View All Result
Whistleblower Network News
The Truth at Any Cost.
Qui Tam, Compliance and Anti-Corruption News.
SIGN THE PETITION FOR NATIONAL WHISTLEBLOWER DAY IN 2023
Whistleblower Network News
  • Qui Tam
  • SEC
  • CFTC
  • FCPA
  • Whistleblower Resources
  • FAQS
Subscribe
Donate
No Result
View All Result
Whistleblower Network News
No Result
View All Result
Home False Claims-Qui Tam

Qui Tam Whistleblower to Receive $200,000 as Part of $1 Million Settlement with Pharmacist and Two Pharmacies 

Ana PopovichbyAna Popovich
December 10, 2021
in False Claims-Qui Tam
Reading Time: 3 mins read
Row of medicines on shelves in a pharmacy
Share on TwitterShare on FacebookShare on LinkedInEmail

Michigan-based pharmacist Riad “Ray” Zahr and two specialty pharmacies that he “formerly owned and operated” will pay the U.S. $1 million “to resolve allegations that they submitted false claims for the drug Evzio,” according to a December 8 U.S. Department of Justice (DOJ) press release. The civil settlement resolves a whistleblower’s allegations, and as part of the settlement the whistleblower will be awarded a share of the government’s recovery.

The press release states that “Evzio was the highest-priced version of naloxone on the market, and insurers frequently required the submission of prior authorization requests before they would approve coverage for Evzio.” The U.S. alleged that between August 1, 2017 and June 30, 2019, “Plymouth Towne Care Pharmacy dba People’s Drug Store (People’s Drug Store) and Shaska Pharmacy LLC dba Ray’s Drugs (Ray’s Drugs) submitted false claims for Evzio to Medicare.” Allegedly, the People’s Drug Store and Ray’s Drugs “submitted false and misleading prior authorization requests for Evzio that contained clinical assertions for which the pharmacies lacked any factual bias.”

The press release states that Zahr and the two pharmacies “initiated Evzio prescriptions based on rudimentary patient lists with only basic biographical details. Zahr and the pharmacies also included assertions in Evzio prior authorization requests purportedly authored by prescribing physicians regarding the comparative effectiveness of Evzio that the pharmacies or Zahr actually authored. The prescribing physicians did not review, sign or submit the prior authorizations at issue.”

Support Whistleblower Network News

The $1 million settlement also resolves claims that Zahr and the two pharmacies “dispensed Evzio prescriptions to Medicare beneficiaries at times without collecting or attempting to collect co-payment obligations for Evzio, in violation of the Anti-Kickback Statute.”

The whistleblower in this case is Rebecca Socol, who formerly worked for Evzio manufacturer kaléo Inc. Socol filed the claims under the qui tam provisions of the False Claims Act, which allow private individuals to file lawsuits on behalf of the U.S. government if an individual or company is defrauding the government. For her involvement in this case, Socol will receive $200,000.

Socol was awarded $2,548,600 in November when kaléo Inc. entered into a $12.7 million settlement with the DOJ. The settlement resolved allegations that the company “caused the submission of false claims” for Evzio.

Officials commenting on the Zahr, People’s Drug Store, and Ray’s Drug Store settlement in the press release mentioned how abuse of federal medical programs disadvantages taxpayers and sows distrust in said programs. “Taxpayers pay a huge amount of money for federal health care programs, and they expect that money will be spent honestly and effectively – especially when it comes to expensive therapies,” said Acting U.S. Attorney Nathaniel R. Mendell for the District of Massachusetts. “Our job is to find and stop misconduct like this, which hurts those programs and cheats us all.”

“When health care providers put their own financial gain above honest billing of Medicare, they violate the basic trust the public extends to health care professionals,” said Special Agent in Charge Phillip M. Coyne of the U.S. Department of Health and Human Services, Office of the Inspector General (HHS OIG).

Special Agent in Charge Joseph R. Bonavolonta of the FBI Boston Division added, “Pharmacies that take shortcuts to increase their profits by submitting false claims for expensive drugs increase medical costs for all of us…Today’s settlement should deter anyone thinking about abusing our federal health care programs that so many rely on for their health care needs.”

Read the DOJ press release here.

\Read more qui tam/False Claims Act news on WNN.

Tags: False Claims / Qui TamFalse Claims ActQui Tam
Previous Post

Bill to Establish FTC Whistleblower Reward Program Introduced

Next Post

Knock on Wood: WWF Exposes Illegal Timber Practices in Germany

Ana Popovich

Ana Popovich

Ana Popovich is a contributing editor with Whistleblower Network News, where she writes about breaking whistleblower news, healthcare fraud whistleblowers, and Covid-19 fraud whistleblowers. Ana has a B.A. in English from Georgetown University. While at Georgetown, she was the marketing chair of an affinity group and wrote content for the McDonough School of Business’ Business for Impact program. In 2018, Popovich was a public interest legal intern at the whistleblower law firm Kohn, Kohn and Colapinto. 

Next Post
Photo: WWF Germany

Knock on Wood: WWF Exposes Illegal Timber Practices in Germany

Receive Daily Alerts

Subscribe to receive daily breaking news and legislative developments sent to your inbox.

  • This field is for validation purposes and should be left unchanged.

Most Popular

US Attorneys Reflect on UK’s Whistleblowing Awareness Week

OSHA Highlights Railroad Worker Whistleblower Protections in Wake of Train Derailments

AML Whistleblower Law Could Shift the Way DOJ Handles Whistleblowers

Two Powerful Women Whistleblower Pairs to Learn From This Women’s History Month

WNN Exclusive Interview with Social Security Whistleblowers Sarah Carver and Jennifer Griffith — Part 2

Change the Culture, Make National Whistleblower Day Permanent

Whistleblower Poll

Whistleblower Poll
Whistleblower Poll

Exclusive Marist Poll: Overwhelming Public Support Among Likely Voters For Increased Whistleblower Protections

byGeoff Schweller
October 6, 2020

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

STAY INFORMED.
Subscribe to receive breaking whistleblower updates.

  • This field is for validation purposes and should be left unchanged.

About Us

  • About
  • Contact Us
  • Donate
  • Careers

Subscribe

  • Daily Mail
  • Follow us on Twitter
  • YouTube Channel

Contribute

  • Letter to the Editor
  • Submission Guidelines
  • Reprint Guidelines

Your Experience

  • Accessibility Statement
  • Privacy Policy
  • Terms of Use

Help

  • The Whistleblowers Handbook
  • Frequently Asked Questions
  • Advertise
Whistleblower Network News

Whistleblower Network News is an independent online newspaper providing our readers with up-to-date information on whistleblowing. Our goal is to be the best source of information on important qui tam, anti-corruption, compliance, and whistleblower law developments. 

Submit an Article

Copyright © 2021, Whistleblower Network News. All Rights Reserved.

This Newspaper/Web Site is made available by the publisher for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this website, you understand that there is no attorney-client relationship between you and the Newspaper/Web Site publisher. The Newspaper/Web Site should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.

SIGN THE PETITION FOR NATIONAL WHISTLEBLOWER DAY IN 2023
No Result
View All Result
  • Exclusives
  • Government
    • False Claims-Qui Tam
    • Federal Employees
    • Intelligence
  • Corporate
    • CFTC & Commodities
    • Dodd-Frank
    • IRS & Tax
    • SEC & Securities
  • Features
  • Legislation
  • International
    • Foreign Corruption
  • Rewards
  • Whistleblower of the Week
  • Environment & Climate
  • Opinion
  • Editorial
  • Employment
    • Sarbanes-Oxley Whistleblowers
    • Retaliation
    • OSHA
  • Media
    • Podcasts
    • Videos
    • Webinars
    • National Whistleblower Day
  • Whistleblower Poll
  • Whistleblower Resources
    • Frequently Asked Questions
    • Resources for Locating An Attorney
    • The New Whistleblowers Handbook
  • National Whistleblower Day ’23

Copyright © 2020, Whistleblower Network News. All Rights Reserved.

Become a Whistleblower Network News Subscriber

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Subscribe to WNN

Retrieve your password

Please enter your username or email address to reset your password.

Subscribe to WNN

Add New Playlist

Go to mobile version